Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022)
Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022)
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Fluorine is characterized by high electronegativity and small atomic size, which provide this molecule with the unique property of augmenting the potency, selectivity, metabolic stability, and pharmacokinetics of drugs. Fluorine (F) substitution has been extensively explored in drug research as a means of improving biological activity and enhancing...
Alternative Titles
Full title
Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_260cf0bcfff64f9abe72bc03541a04f1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_260cf0bcfff64f9abe72bc03541a04f1
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph16081162
